| Product Code: ETC8856198 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Antimicrobial Resistance Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Poland Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Poland Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Poland Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Poland Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Poland Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Poland Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Poland |
4.2.2 Rising awareness about the importance of combating antimicrobial resistance |
4.2.3 Government initiatives to promote responsible use of antibiotics |
4.3 Market Restraints |
4.3.1 Limited availability of new antibiotics |
4.3.2 High costs associated with developing new antimicrobial drugs |
4.3.3 Lack of standardized guidelines for antimicrobial stewardship in healthcare settings |
5 Poland Antimicrobial Resistance Market Trends |
6 Poland Antimicrobial Resistance Market, By Types |
6.1 Poland Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Poland Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Poland Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Poland Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Poland Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Poland Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Poland Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Poland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Poland Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Poland Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Poland Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Poland Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Poland Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Poland Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Poland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Poland Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Poland Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Poland Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Poland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Poland Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Poland Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Poland Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Poland Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Poland Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Poland Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Poland Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Poland Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Poland Antimicrobial Resistance Market Export to Major Countries |
7.2 Poland Antimicrobial Resistance Market Imports from Major Countries |
8 Poland Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities following antimicrobial stewardship protocols |
8.2 Number of antibiotic-resistant infections reported annually |
8.3 Percentage of healthcare professionals trained in antimicrobial resistance management |
9 Poland Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Poland Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Poland Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Poland Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Poland Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Poland Antimicrobial Resistance Market - Competitive Landscape |
10.1 Poland Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Poland Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here